Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Marco Palmas

Safety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program

Oncologist

English

Related publications

Fixed Combination of Oral NEPA (Netupitant‐palonosetron) for the Prevention of Acute and Delayed Chemotherapy‐induced Nausea and Vomiting in Patients Receiving Multiple Cycles of Chemotherapy: Efficacy Data From 2 Randomized, Double‐blind Phase III Studies

English

Drug–drug Interaction Profile of Components of a Fixed Combination of Netupitant and Palonosetron: Review of Clinical Data

Journal of Oncology Pharmacy Practice

English

Pcn174 - Nepa, an Oral Fixed Combination of Netupitant and Palonosetron, Is a Cost-Effective Intervention for the Prevention of Chemotherapy-Induced Nausea and Vomiting (Cinv) in Germany and Greece

English

Preventing Chemotherapy-Induced Nausea and Vomiting With Netupitant/Palonosetron, the First Fixed Combination Antiemetic: Current and Future Perspective

English

Safety of Ipragliflozin in Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical Trials

English

Pooled Analysis of Safety Data From Pediatric Phase II RTS,S/AS Malaria Candidate Vaccine Trials

Human Vaccines

2011

English

Postoperative Opioid Sparing With Injectable Hydroxypropyl-Β-Cyclodextrin-Diclofenac: Pooled Analysis of Data From Two Phase III Clinical Trials

Journal of Pain Research

Anesthesiology

Pain Medicine

2016

English

Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2

English

Using Phase II Data for the Analysis of Phase III Studies: An Application in Rare Diseases

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Marco Palmas

Safety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program

Related publications

Fixed Combination of Oral NEPA (Netupitant‐palonosetron) for the Prevention of Acute and Delayed Chemotherapy‐induced Nausea and Vomiting in Patients Receiving Multiple Cycles of Chemotherapy: Efficacy Data From 2 Randomized, Double‐blind Phase III Studies

Drug–drug Interaction Profile of Components of a Fixed Combination of Netupitant and Palonosetron: Review of Clinical Data

Pcn174 - Nepa, an Oral Fixed Combination of Netupitant and Palonosetron, Is a Cost-Effective Intervention for the Prevention of Chemotherapy-Induced Nausea and Vomiting (Cinv) in Germany and Greece

Preventing Chemotherapy-Induced Nausea and Vomiting With Netupitant/Palonosetron, the First Fixed Combination Antiemetic: Current and Future Perspective

Safety of Ipragliflozin in Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical Trials

Pooled Analysis of Safety Data From Pediatric Phase II RTS,S/AS Malaria Candidate Vaccine Trials

Postoperative Opioid Sparing With Injectable Hydroxypropyl-&Beta;-Cyclodextrin-Diclofenac: Pooled Analysis of Data From Two Phase III Clinical Trials

Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2

Using Phase II Data for the Analysis of Phase III Studies: An Application in Rare Diseases

Postoperative Opioid Sparing With Injectable Hydroxypropyl-Β-Cyclodextrin-Diclofenac: Pooled Analysis of Data From Two Phase III Clinical Trials